-
Sector Analysis
Pancreatic Cancer in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
This report covers the 8MM (US, France, Germany, Italy, Spain, UK, China, and Japan) and includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Pancreatic cancer. These sales forecasts leverage data on pharmaceutical sales and drug availability from GlobalData’s World Markets Healthcare (WMH) and POLI Price Intelligence databases. Key Highlights - Report deliverables include an Excel-based forecast model - Forecasts...
-
Sector Analysis
Antibody-Drug Conjugates - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the cytotoxic effects of chemotherapy drugs. The antibodies are designed to target specific antigens on cancer cells, allowing the attached chemotherapy drug to be delivered directly to the tumor cells while sparing healthy cells. This targeted approach reduces side effects and improves the efficacy of the treatment. ADCs have shown promising results in clinical trials for various types of cancer, including breast...
-
Sector Analysis
Engineered Multispecific antibodies - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Engineered Multispecific Antibodies Report Overview Multi-specific antibodies that are engineered to recognize two or more epitopes located on the same or distinct targets are a high-impact innovation and will continue to remain so in the near-term. Engineered multi-specific antibodies is an accelerating innovation among 80+ key innovation areas in the pharma industry according to the innovation s-curve framework. Innovation S-Curve – Innovation Areas Buy the Full Report for More Engineered Multispecific Antibodies Innovation Insights, Download a Free Report Sample Engineered...
-
Sector Analysis
Antibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products, Opportunities and Challenges
Reasons to buy the ‘Antibody-Drug Conjugates (ADC)’ industry analysis report: Gain insight into the competitive landscape of leading antibody-drug conjugates (ADC) through this report. Get access to SWOT analysis for key marketed and pipeline drugs, clinical benchmark comparisons, key clinical trial analysis, analyst consensus forecasts, and commentary on current and future players. Examine the outlook of four key opinion leaders in the US and analyze key opportunities and challenges in the space. The report provides commentary on the latest trends...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.